Immunofluorescence staining was applied to analyse the expression of carbonic anhydrase IX (CAIX, an established cellular biomarker of hypoxia), ZEB1, CD163 (an M2-like TAM marker in human), CD47 and SIRPα in tissues derived from CSCC patients. The gene discussed is CA9; the disease is skin squamous cell carcinoma.